Page 83 - Memoria SEHH 2022

MEMORIA ANUAL 2022 SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE HEMATOLOGÍA Y HEMOTERAPIA
• Progression Risk and Long-Term Survival Trends of 915 Patients with Asymptomatic IgM Monoclonal Gammopathy.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Moreno DF, Jiménez C, Escalante Barrigón F, Askari E, Arnao M, Heredia A, Alcalá M, Bermúdez A, Saus Carreres A, Casanova M, Palomera L, Motllo C, García Sánchez RB, García-Sanz R, Fernández de Larrea C .
Grupo de trabajo coautor: GEM .
• Ultra-Sensitive Assessment of Measurable Residual Disease (MRD) in Peripheral Blood (PB) of Multiple Myeloma (MM) Patients Using Bloodflow.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Notarfranchi L, Zherniakova A, Lasa M, Puig N, Cedena MT, Martínez-López J, Calasanz MJ, Alignani D, Burgos L, Manrique I, Huang JH, Fracowiak J, Gómez C, De Arriba F, Ro- dríguez-Otero P, Palomera L, Sureda A, Clavero Sánchez ME, Álvarez MA, Ibáñez García A, Hernández MT, Pérez A, González AP, Ocio EM, Flores-Montero J, Orfao A, Lahuerta JJ, Mateos MV, Rosiñol L, Bladé Creixenti J, San-Miguel J, Paiva B .
Grupo de trabajo coautor: GEM .
• Clinical Impact of Next Generation Flow in Bone Marrow Vs Qip-Mass Spectrometry in Peripheral Blood to Assess Minimal Residual Disease in Newly Diagnosed Multiple Myeloma Patients Receiving Maintenance As Part of the GEM2014MAIN Trial.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Puig N, Agulló C, Contreras Sanfeliciano T, Paiva B, Cedena MT, Rosiñol Dachs L, García- Sanz R, Martínez-López J, Oriol A, Blanchard MJ, Ríos R, Martín J, Sureda A, Hernández M, de la Rubia J, Moraleda JM, De Arriba F, Palomera L, Íñigo B, Bargay J, Bladé Creixenti J, San-Miguel J, Lahuerta JJ, Mateos MV .
Grupo de trabajo coautor: GEM .
• Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis during Maintenance Is an Independent Prognostic Factor for Multiple Myeloma and Could Complement Prognosis Value of Minimal Residual Disease.
64th American Society of Hematology Annual Meeting and Exposition 2022 (ASH 2022). New Orleans, LA, USA: 10-13 Dec 2022. Hybrid event.
Lakhwani S, Rosiñol Dachs L, Puig N, Pico Picos MA, Medina-González L, Martínez-López J, Paiva B, Oriol A, Ríos R, Blanchard MJ, Jarque I, Bargay J, Moraleda JM, Carrillo-Cruz E, Sureda A, Krsnik I, González García E, Casado Montero LF, Martí JM, Encinas C, De Arriba
83